Experimental therapy SNC116 put to the test against Hard-to-Treat leukemia
Cure
Not yet recruiting
Researchers are testing an experimental therapy called SNC116 in adults with B-cell acute lymphoblastic leukemia that has returned or stopped responding to treatment. The early-stage study enrolls about 28 people and focuses on safety, side effects, and how the body processes the…
Early phase 1 • Sponsor: Shanghai Simnova Biotechnology Co.,Ltd. • Aim: Cure
Last updated Sep 21, 2026 22:00 UTC